High glucose inhibits glucose‐6‐phosphate dehydrogenase, leading to increased oxidative stress and β‐cell apoptosis
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Patients with type 2 diabetes lose β cells, but the underlying mechanisms are incompletely understood. Glucose‐6‐phosphate dehydrogenase (G6PD) is the principal source of the major intracellular reduc‐tant, NADPH, which is required by many enzymes, including enzymes of the antioxidant pathway. Previous work from our laboratory has shown that high glucose impairs G6PD activity in endothelial and kidney cells, which leads to decreased cell survival. Pancreatic β cells are highly sensitive to increased ROS. This study aimed to determine whether G6PD and NADPH play central roles in β‐cell survival. Human and mouse islets, MIN6 cell line, and G6PD deficient mice were studied. High glucose inhibited G6PD expression and activity. Inhibition of G6PD with siRNA led to increased ROS and apoptosis, decreased proliferation, and impaired insulin secretion. High glucose decreased insulin secretion, which was improved by overexpressing G6PD. G6PD‐deficient mice had smaller islets and impaired glucose tolerance compared with control mice, which suggests that G6PD deficiency per se leads to β‐cell dysfunction and death. G6PD plays an important role in β‐cell function and survival. High‐glucose‐mediated decrease in G6PD activity may provide a mechanistic explanation for the gradual loss of β cells in patients with diabetes.—Zhang, Z., Liew, C. W., Handy, D. E., Zhang, Y., Leopold, J. A., Hu, J., Guo, L., Kulkarni, R. N., Loscalzo, J., Stanton, R. C. High glucose inhibits glucose‐6‐phosphate dehydrogenase, leading to increased oxidative stress and β‐cell apoptosis. FASEB J. 24, 1497–1505 (2010). www.fasebj.org
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, acquired deficiency of G6PD caused by high glucose-mediated inhibition of G6PD expression and activity increases ROS generation in pancreatic islet cells (476).”
From Redox regulation of mitochondrial function (2012) · cites this paper as [476]
Citations
Cites
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
Diabetes, oxidative stress, and antioxidants: A review
Maritim, A. C., Sanders, R. A., & Watkins, J. B. (2003) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.10058 · Cited by 3,124
Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.
Baynes, J. W., & Thorpe, S. R. (1999) · Diabetes · doi:10.2337/diabetes.48.1.1 · Cited by 2,441
Tiedge, M., Lortz, S., Drinkgern, J., & Lenzen, S. (1997) · Diabetes · doi:10.2337/diab.46.11.1733 · Cited by 1,208
Oxidative Stress as a Major Culprit in Kidney Disease in Diabetes
Forbes, J. M., Coughlan, M. T., & Cooper, M. E. (2008) · Diabetes · doi:10.2337/db08-0057 · Cited by 1,203
Lenzen, S., Drinkgern, J., & Tiedge, M. (1996) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(96)02051-5 · Cited by 1,165
Robertson, R. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.r400019200 · Cited by 1,078 · cited 2×
“Possible sources of increased ROS production in diabetes include glyceraldehyde autooxidation, increased aldose reductase reactivity and resultant decrease in NADPH, increased production of superoxide from mitochondria, and others (1, 33, 34, 38).”
Backgroundβ-Cell Glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes.
Robertson, R. P., Harmon, J., Tran, P. O. T., & Poitout, V. (2004) · Diabetes · doi:10.2337/diabetes.53.2007.s119 · Cited by 914
β-Cell Failure in Diabetes and Preservation by Clinical Treatment
Wajchenberg, B. L. (2007) · Endocrine Reviews · doi:10.1210/10.1210/er.2006-0038 · Cited by 714
Sakuraba, H., Mizukami, H., Yagihashi, N., Wada, R., Hanyu, C., & Yagihashi, S. (2002) · Diabetologia · doi:10.1007/s125-002-8248-z · Cited by 681
Cited by
Items 201–226 of 226
Characterization Of Mango Peel Mangiferin To Elucidate Its Nutraceutical Potential
Muhammad, I. (2013) · HEC National Digital Library
Marunych, R. Y. (2013) · Biopolymers and Cell · doi:10.7124/bc.00080d
“There are many known pathologies, related to the states of this enzyme deficiency and its various mutations, including neonatal jaundice [43], impairment of -cells in conditions of high glucose content at diabetes [44], chronic erythrolysis and megalocytic anemia [45], polycyctic ovarian disease [46], etc.”
Munhoz, A. C. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.42.2014.tde-11122014-103120
Insights into the metabolic regulation of insulin secretion using a metabolomics approach
Huang, M. (2014) · UWSpace (University of Waterloo)
Changes in Glucose-6-phosphate Dehydrogenase Activity in Paroxysmal Atrial Fibrillation
Negreva, M. N., Penev, A., Georgiev, S., & Alexandrova, A. (2014) · Journal of Cardiobiology · doi:10.13188/2332-3671.1000008
“GSH prevents the oxidative damage of the nucleic acids, lipids and proteins by neutralizing directly the physiological and pathologically generated active oxygen forms.”
BackgroundInfluentialSociobiological Transition and Cancer: Prospects for Africa
Mohammed, S. I., Alfarouk, K. O., El-Hassan, A. M., Hamad, K., & Ibrahim, M. E. (2019) · Cambridge University Press eBooks · doi:10.1017/9781139680295.010
Regenerative Therapies for Acquired Axonal Neuropathies
Wilcox, M., Cetinkaya‐Fisgin, A., & Höke, A. (2020) · Springer eBooks · doi:10.1007/978-3-030-06217-0_19-1
Redox Signaling is Essential for Insulin Secretion
Ježek, P., Holendová, B., Jabůrek, M., Tauber, J. A., Dlasková, A., & Plecitá‐Hlavatá, L. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.94312
PathoBiochemistry-directed Guidelines for COVID-19Preprint
Buinitskaya, Y., Wlodaver, C. G., Gurinovich, R., & Kastsiuchenka, S. (2021) · Preprints.org · doi:10.20944/preprints202106.0653.v1
Goren, T. A. (2023) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2023.256
Chang, Y.-L., Nfor, O. N., Chou, Y., Hsiao, C.-H., Zhong, J.-H., Huang, C., & Liaw, Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-63361-9
Alsubaie, H. A., Alsubaie, G. A., & Almusalami, A. M. (2024) · Cureus · doi:10.7759/cureus.61656
“Furthermore, recent studies have shown that increased blood sugar levels such as in diabetic ketoacidosis (DKA) conditions can further impair the function of the G6PD enzyme, causing further cell damage and hemolysis [6].”
BackgroundLundquist, I., Al-Amily, I. M., Henningsson, R. N., & Salehi, A. A. (2025) · PLoS ONE · doi:10.1371/journal.pone.0315126
Jung, S. H., Roy, R., Zhao, Y. Q., O’Connell, T. M., Wohlford, R. K., Kim, D.-H., Hao, C., & Bellail, A. C. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.08.647644
“Cell growth assay showed that G6PD knockdown significantly reduced cell proliferation in two different clones (Figure 5C), consistent with the findings in G6PD knockdown in other cancer cells 26,31,32 .”
Marinelli, S., Rossi, C., Pieroni, L., Giacovazzo, G., Vacca, V., Angelis, F. D., Cicalini, I., Mastrorilli, V., Parisi, C., Yurtsever, Z. N., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.17.659987
Gosling, A. L. (2012) · Otago University Research Archive (University of Otago)
Yeom, C., Lee, J., Bae, K.-J., Kim, K., Choi, J., & Lim, M. (2025) · Cancers · doi:10.3390/cancers18010041
Sethna, C. R., Niemes, M. D. C. M., Waters, B. J., Wagner, M. R., Smith, J., Nimkulrat, S. D., Lemanski, J., Pintozzi, N. G., Sardo, V. L., & Blum, B. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.12.711435
Wang, Y., Song, D., Wu, T., & Othman, E. M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27114734 · Cited by 1
“Hyperglycemia-induced oxidative stress inhibits glucose-6-phosphate dehydrogenase, the rate-limiting enzyme of the PPP [93,94].”
Li, T., Jiang, C., Li, Q.-H., Hu, M.-M., Li, Y., Yao, Y., Ma, Y., Wang, Y., & Chen, J. (2026) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(26)61098-9
The Role of Cytochrome P450 Holoenzyme Metabolism in the Origin of Neuropathologies
Štambuk, S. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27156971
Camara, L. R. P., & Vilas‐Boas, E. A. (2026) · Frontiers in Network Physiology · doi:10.3389/fnetp.2026.1864821
The comparative cell physiology of stem cell-derived and primary human β cells
Maghera, J., Chu, C. M. J., Schaaf, C., Bruin, J. E., Johnson, J. D., Lynn, F. C., & MacDonald, P. E. (2026) · Nature Reviews Endocrinology · doi:10.1038/s41574-026-01295-0 · Cited by 1
Wang, J., Zhang, L., Wang, X., Li, J., & Kang, Y. (2026) · Endocrine · doi:10.1007/s12020-026-04736-y
Sarhandi, P. Z. J., Sarhandi, P. I. J., Cockburn, B. N., Brennan, M., & Sreenan, S. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113567
Metadata
- Authors
- Zhang, Z., Liew, C. W., Handy, D. E., Zhang, Y., Leopold, J. A., Hu, J., Guo, L., Kulkarni, R. N., Loscalzo, J., & Stanton, R. C.
- Affiliations
- Joslin Diabetes Center (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Stanton, Robert C.
- ORCID
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2009-12-23
- Volume
- 24
- Issue
- 5
- Pages
- 1497-1505
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- PMC
- PMC2879949
- OpenAlex
- W2025512372
- Cited by
- 226
- References
- 50
- Citations by year
- 2026: 10 · 2025: 13 · 2024: 12 · 2023: 11 · 2022: 15 · 2021: 16 · 2020: 12 · 2019: 19 · 2018: 9 · 2017: 10 · 2016: 16 · 2015: 13 · 2014: 13 · 2013: 13 · 2012: 20
- FWCI
- 14.37
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The FASEB Journal (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (R01–DK54380)
- National Heart, Lung, and Blood Institute (HL 61795, N01 HV 28178, P01 HL 81857, U54 HL 070819)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Keywords
- glucose-6-phosphate dehydrogenase, high glucose, pancreatic beta cells, beta-cell apoptosis, oxidative stress, reactive oxygen species, NADPH, type 2 diabetes, beta-cell dysfunction, insulin secretion, glucose tolerance, beta-cell survival
- MeSH terms
- Insulin Secretion, Animals, Blood Glucose, Cell Line, Cell Survival, Diabetes Mellitus, Type 2, Glucosephosphate Dehydrogenase, Humans, Hyperglycemia, Insulin, Mice, Mutant Strains, Apoptosis, Reactive Oxygen Species, Oxidative Stress, Insulin-Secreting Cells, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.